XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
BASIS OF PRESENTATION (Tables)
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Amounts Reclassified
The following table provides the amounts reclassified for the three months ended March 31, 2023.
Three Months Ended March 31, 2023
(in thousands)As previously reportedRe-classificationsAs reclassifiedAs currently reported
Costs of revenue (exclusive of amortization and depreciation)
RCM$27,183 $— $27,183 $27,183 
EHR16,348 — 16,348 16,348 
Patient engagement646 — 646 646 
Other expenses
Product development9,836 (1,484)8,352 8,352 
Sale and marketing6,959 (2)6,957 6,957 
General and administrative14,952 (499)14,453 14,453 
Amortization of acquisition-related intangibles4,014 (4,014)— — 
Amortization— 5,500 5,500 5,500 
Depreciation— 499 499 499